Empirical Finance, LLC Abbott Laboratories Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

A detailed history of Empirical Finance, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Empirical Finance, LLC holds 60,360 shares of ABT stock, worth $7.12 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
60,360
Previous 59,025 2.26%
Holding current value
$7.12 Million
Previous $6.13 Million 12.2%
% of portfolio
0.41%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$100.07 - $118.13 $133,593 - $157,703
1,335 Added 2.26%
60,360 $6.88 Million
Q2 2024

Jul 30, 2024
SELL
$100.73 - $112.44 $428,807 - $478,657
-4,257 Reduced 6.73%
59,025 $6.13 Million
Q1 2024

May 06, 2024
BUY
$109.52 - $120.96 $269,966 - $298,166
2,465 Added 4.05%
63,282 $7.19 Million
Q3 2023

Nov 02, 2023
BUY
$95.53 - $114.62 $554,933 - $665,827
5,809 Added 10.56%
60,817 $5.89 Million
Q2 2023

Jul 27, 2023
BUY
$100.78 - $112.29 $618,184 - $688,786
6,134 Added 12.55%
55,008 $6 Million
Q1 2023

Apr 05, 2023
BUY
$96.86 - $114.01 $231,882 - $272,939
2,394 Added 5.15%
48,874 $4.95 Million
Q4 2022

Jan 24, 2023
BUY
$95.06 - $111.52 $348,870 - $409,278
3,670 Added 8.57%
46,480 $5.1 Million
Q3 2022

Nov 04, 2022
BUY
$96.76 - $112.03 $668,901 - $774,463
6,913 Added 19.26%
42,810 $4.14 Million
Q2 2022

Aug 01, 2022
BUY
$102.07 - $123.37 $196,280 - $237,240
1,923 Added 5.66%
35,897 $3.9 Million
Q1 2022

Apr 21, 2022
BUY
$114.02 - $139.04 $421,988 - $514,587
3,701 Added 12.23%
33,974 $4.02 Million
Q4 2021

Feb 04, 2022
BUY
$115.53 - $141.46 $931,518 - $1.14 Million
8,063 Added 36.3%
30,273 $4.26 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $150,841 - $166,874
1,293 Added 6.18%
22,210 $2.62 Million
Q2 2021

Aug 10, 2021
BUY
$105.79 - $124.53 $306,791 - $361,137
2,900 Added 16.1%
20,917 $2.43 Million
Q4 2020

Feb 02, 2021
BUY
$105.0 - $114.42 $333,060 - $362,940
3,172 Added 21.37%
18,017 $1.97 Million
Q3 2020

Oct 28, 2020
BUY
$91.64 - $111.29 $986,779 - $1.2 Million
10,768 Added 264.12%
14,845 $1.62 Million
Q3 2020

Oct 26, 2020
SELL
$91.64 - $111.29 $696,189 - $845,470
-7,597 Reduced 65.08%
4,077 $341,000
Q2 2020

Jul 20, 2020
BUY
$76.57 - $98.0 $378,944 - $485,002
4,949 Added 73.59%
11,674 $1.07 Million
Q2 2020

Jul 20, 2020
SELL
$76.57 - $98.0 $267,305 - $342,118
-3,491 Reduced 34.17%
6,725 $1.07 Million
Q1 2020

Apr 16, 2020
BUY
$62.82 - $91.86 $232,371 - $339,790
3,699 Added 56.76%
10,216 $806,000
Q4 2019

Jan 27, 2020
BUY
$78.51 - $87.4 $191,564 - $213,256
2,440 Added 59.85%
6,517 $566,000
Q3 2019

Oct 30, 2019
BUY
$81.84 - $88.74 $6,629 - $7,187
81 Added 2.03%
4,077 $341,000
Q2 2019

Jul 09, 2019
SELL
$72.88 - $85.0 $5,684 - $6,630
-78 Reduced 1.91%
3,996 $336,000
Q1 2019

May 10, 2019
BUY
$66.22 - $80.06 $63,902 - $77,257
965 Added 31.04%
4,074 $326,000
Q4 2018

Jan 22, 2019
SELL
$65.56 - $74.27 $15,865 - $17,973
-242 Reduced 7.22%
3,109 $225,000
Q3 2018

Oct 18, 2018
BUY
$60.81 - $73.36 $203,774 - $245,829
3,351 New
3,351 $246,000
Q2 2018

Jul 09, 2018
SELL
$57.57 - $63.54 $234,540 - $258,861
-4,074 Closed
0 $0
Q1 2018

May 10, 2019
BUY
$56.27 - $63.62 $229,243 - $259,187
4,074 New
4,074 $326,000
Q4 2017

Feb 01, 2018
SELL
$53.68 - $57.47 $273,070 - $292,349
-5,087 Closed
0 $0
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $44,503 - $49,670
926 Added 22.25%
5,087 $272,000
Q2 2017

Aug 10, 2017
BUY
N/A
4,161
4,161 $203,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email